Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals

被引:27
|
作者
Ribas, SG
Ondoa, P
Schüpbach, J
van der Groen, G
Fransen, K
机构
[1] Inst Trop Med, B-2000 Antwerp, Belgium
[2] Univ Zurich, Swiss Natl Ctr Retroviruses, Zurich, Switzerland
关键词
HIV-1; RNA; viral load; heat-denatured p24 antigen; HIV subtypes;
D O I
10.1016/S0166-0934(03)00219-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The heat-denatured signal-amplified p24 antigen assay is a low-cost test allowing the determination of plasma levels of HIV-1 p24 antigen in infected patients. This assay may be appropriate for monitoring disease progression in HIV seropositive patients in developing countries. Only a few data on the clinical validation of the test are available for HIV-1 non-subtypes B viruses that represent the vast majority of virus circulating in Africa. The present study was undertaken to evaluate and compare the performance of a heat-denatured signal-amplified p24 assay for the determination of p24 viral load in the plasma of individuals infected with different subtypes of HIV-1 and using the RT-PCR-based RNA viral load test as the gold standard. A total of 120 plasma samples from individuals infected with HIV-1 strains belonging to group M (subtypes A --> H) and group O, as well as recombinant strains, were tested in parallel with the heat-denatured signal-amplified p24 assay and the RNA viral load. Plasma p24 levels appeared to be correlated significantly with the plasma RNA viral loads (R = 0.751, P < 0.0001). The heat-denatured p24 antigen assay was capable of measuring the plasma level of p24 derived from all the HIV-1 subtypes and recombinants selected for this study, in contrast to the RNA viral load test which lacked sensitivity towards HIV-1 group O. The heat-denatured signal-amplified p24 assay is a reliable, sensitive and a more affordable tool that can be used for the follow-up of patients infected with B and non-B subtypes as well as recombinant forms of HIV-1 in developing countries. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 50 条
  • [41] Antiviral activity of Rwandan medicinal plants against human immunodeficiency virus type-1 (HIV-1)
    Cos, P
    Hermans, N
    De Bruyne, T
    Apers, S
    Sindambiwe, JB
    Witvrouw, M
    De Clercq, E
    Vanden Berghe, D
    Pieters, L
    Vlietinck, AJ
    PHYTOMEDICINE, 2002, 9 (01) : 62 - 68
  • [42] Inhibition of Human Immunodeficiency Type 1 Virus (HIV-1) Life Cycle by Different Egg White Lysozymes
    Behbahani, Mandana
    Nosrati, Mokhtar
    Mohabatkar, Hassan
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2018, 185 (03) : 786 - 798
  • [43] The effect of human immunodeficiency virus type 1 (HIV-1) gp41 variability on antibody detection
    Nie, Jianhui
    Song, Aijing
    Xu, Sihong
    Li, Xiuhua
    Wang, Youchun
    ARCHIVES OF VIROLOGY, 2010, 155 (11) : 1813 - 1822
  • [44] NK CELLS: CHARACTERISTICS AND ROLE DURING THE INFECTION BY TYPE-1 HUMAN IMMUNODEFICIENCY VIRUS (HIV-1)
    Moreno Fernandez, Maria Eugenia
    Montoya Guarin, Carlos Julio
    Rugeles Lopez, Maria Teresa
    IATREIA, 2007, 20 (01) : 47 - 63
  • [45] Changes in the topology of gene expression networks by human immunodeficiency virus type 1 (HIV-1) integration in macrophages
    Soto-Giron, Maria Juliana
    Garcia-Vallejo, Felipe
    VIRUS RESEARCH, 2012, 163 (01) : 91 - 97
  • [46] Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism
    Muthumani, K
    Choo, AY
    Premkumar, A
    Hwang, DS
    Thieu, KP
    Desai, BM
    Weiner, DB
    CELL DEATH AND DIFFERENTIATION, 2005, 12 (Suppl 1) : 962 - 970
  • [47] Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury
    Debjani Guha
    Marc C. E. Wagner
    Velpandi Ayyavoo
    Journal of Neuroinflammation, 15
  • [48] Antiviral activity of Hawaiian medicinal plants against human immunodeficiency virus type-1 (HIV-1)
    Locher, CP
    Witvrouw, M
    deBethune, MP
    Burch, MT
    Mower, HF
    Davis, H
    Lasure, A
    Pauwels, R
    deClercq, E
    Vlietinck, AJ
    PHYTOMEDICINE, 1996, 2 (03) : 259 - 264
  • [49] Molecular monitoring of human immunodeficiency virus type 1 infection
    Clementi, M
    Bagnarelli, P
    Menzo, S
    Cardelli, M
    Mazzola, F
    Sampaolesi, R
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1997, 11 (1-2) : 64 - 68
  • [50] Concomitant Lethal Mutagenesis of Human Immunodeficiency Virus Type 1
    Dapp, Michael J.
    Holtz, Colleen M.
    Mansky, Louis M.
    JOURNAL OF MOLECULAR BIOLOGY, 2012, 419 (3-4) : 158 - 170